Insiders · INBX

Mark Lappe

Chief Executive Officer, Director at Inhibrx Biosciences, Inc. (INBX)

Mark Lappe has filed 14 insider reports with the SEC since January 2021, as chief Executive Officer and director at Inhibrx Biosciences, Inc. (INBX). In the last 12 months Mark Lappe bought $3.64M of stock on the open market. In the latest filing, on September 28, 2026, Mark Lappe bought 10,000 shares of Inhibrx Biosciences, Inc. (INBX) for $999K at an average of $99.88.

Filings
14
Companies
1
Bought on market
$6.06M
Sold on market
$2.82M

Companies where Mark Lappe is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Inhibrx Biosciences, Inc. logo
INBX
Inhibrx Biosciences, Inc.
Chief Executive Officer, Director$6.06M$2.82M$30.45$74.18+144%Sep 28, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Mark Lappe with

Other insiders at the same companies

Questions about Mark Lappe

What is Mark Lappe's role at Inhibrx Biosciences, Inc.?
Mark Lappe reports to the SEC as chief Executive Officer and director at Inhibrx Biosciences, Inc. (INBX), according to the latest filing on September 28, 2026.
Has Mark Lappe bought or sold stock recently?
The most recent open-market purchase was on September 28, 2026: bought 10,000 shares of Inhibrx Biosciences, Inc. (INBX) for $999K at an average of $99.88. The most recent open-market sale was on February 28, 2023: sold 60 shares of Inhibrx, Inc. (INBX) for $1,501 at an average of $25.02.
How do I get alerts when Mark Lappe files?
Follow Mark Lappe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Lappe filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark Lappe (SEC CIK 0001366074). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR